| 1340 |
National Cancer Institute |
Html |
en |
Cigar Smoking and Cancer |
A fact sheet about the health risks associated with cigar smoking. |
| U.S. cigarettes | 0.435012 |
| safe level | 0.447421 |
| daily cigar smokers | 0.575561 |
| lung disease | 0.3915 |
| U.S. Department | 0.408687 |
| Tobacco Control Research | 0.449796 |
| cigarette wrappers | 0.39436 |
| fact sheet | 0.390339 |
| smoking cigarettes | 0.411876 |
| cigar smoke | 0.9529 |
| smaller cigar | 0.493729 |
| higher level | 0.393813 |
| tobacco wrapper | 0.424842 |
| tobacco | 0.68829 |
| little cigars | 0.531809 |
| cancer-causing chemicals | 0.523406 |
| single cigar | 0.473523 |
| tobacco equivalent | 0.423502 |
| tobacco smoke | 0.637174 |
| nicotine replacement therapy | 0.395273 |
| premium cigars | 0.430441 |
| cigar tobacco | 0.599849 |
| Yes. Cigar smoke | 0.635443 |
| Cigar smoking causes | 0.545544 |
| tobacco products | 0.458198 |
|
| nonporous cigar wrapper | 0.527496 |
| longer smoking time | 0.409949 |
| cigar sizes | 0.492999 |
| Step-by-Step Quit Guide | 0.399635 |
| nicotine replacement products | 0.450092 |
| cigar smokers | 0.686977 |
| cigarettes | 0.521293 |
| help quitting smoking | 0.41788 |
| NCI fact sheet | 0.38899 |
| cigar smoking | 0.555875 |
| Cigar wrappers | 0.48618 |
| cigarette smoke | 0.705986 |
| heart disease | 0.392368 |
| large cigars | 0.512534 |
| esophageal cancer risks | 0.38664 |
| cigarette tobacco | 0.465692 |
| cigars | 0.636157 |
| cigarette smokers | 0.616772 |
| cigar smoking. Journal | 0.511307 |
| oral cavity cancers | 0.409515 |
| Services. Reducing Tobacco | 0.446373 |
| Regular cigar smokers | 0.574584 |
| oral cavity | 0.439868 |
| safe tobacco product | 0.484172 |
|
CLICK HERE |
| 1459 |
National Cancer Institute |
Html |
en |
Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)–Health Professional Version |
Endocrine and neuroendocrine neoplasias may be inherited in syndromes such as multiple endocrine neoplasia types 1 and 2 (MEN1 and MEN2), familial pheochromocytoma and paraganglioma, and Carney-Stratakis syndrome. Learn about the genetics, clinical manifestations, and management of these hereditary cancer syndromes in this expert-reviewed summary. |
| men1 gene | 0.496062 |
| endocrine neoplasia syndrome | 0.465022 |
| moderate-risk pathogenic variants | 0.451346 |
| Zollinger-Ellison syndrome | 0.472267 |
| gene pathogenic variant | 0.461604 |
| familial multiple endocrine | 0.465896 |
| MEN1 pathogenic variant. | 0.494678 |
| M918T pathogenic variants | 0.452285 |
| Ann Surg | 0.450141 |
| Dutch MEN1 Study | 0.479758 |
| gene pathogenic variants | 0.465665 |
| pathogenic variant detection | 0.451143 |
| pathogenic variant testing | 0.449159 |
| Common pathogenic variants | 0.452259 |
| C634R pathogenic variant | 0.448895 |
| recent Dutch MEN1 | 0.461537 |
| family members | 0.473057 |
| MEN1 section | 0.451905 |
| specific pathogenic variants | 0.452497 |
| patients | 0.486964 |
| ATA-H pathogenic variants | 0.452298 |
| Preoperative multiple endocrine | 0.451658 |
| certain endocrine tumors | 0.451569 |
| Clin Endocrinol Metab | 0.506906 |
|
| MEN1 multicenter study | 0.456509 |
| pathogenic variant analysis | 0.462761 |
| et al. | 0.511423 |
| pancreaticoduodenal endocrine tumors | 0.47075 |
| MEN1 diagnosis | 0.459578 |
| MEN1 testing | 0.457802 |
| MEN1 pathogenic variants | 0.509643 |
| endocrine neoplasia type | 0.912503 |
| PUBMED Abstract | 0.487944 |
| multiple endocrine neoplasia | 0.985247 |
| pathogenic variants | 0.602394 |
| term pathogenic variant | 0.454804 |
| MEN1 Study Group | 0.48033 |
| pathogenic variant yield | 0.450166 |
| primary hyperparathyroidism | 0.470964 |
| RET pathogenic variant | 0.455734 |
| pathogenic variant prevalence | 0.453316 |
| RET pathogenic variants | 0.474875 |
| pancreatic endocrine tumors | 0.459209 |
| Abstract | 0.518889 |
| C634Y pathogenic variant | 0.449059 |
| calcitonin levels | 0.449053 |
| term multiple endocrine | 0.45844 |
| germline pathogenic variants | 0.463296 |
|
CLICK HERE |
| 1625 |
National Cancer Institute |
Html |
en |
Vulvar Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of vulvar cancer. |
| clinical trial | 0.306795 |
| treatment | 0.33468 |
| vulvar cancer | 0.816472 |
| lymph node biopsy | 0.279435 |
| vulvar intraepithelial neoplasia | 0.273676 |
| sentinel lymph node | 0.432305 |
| cancer cells | 0.248189 |
| Recurrent vulvar cancer | 0.242509 |
|
| PDQ cancer information | 0.200769 |
| Radical local excision | 0.22415 |
| cancer clinical trials | 0.214832 |
| lymph nodes | 0.572468 |
| radiation therapy | 0.379761 |
| National Cancer Institute | 0.219981 |
| cancer | 0.970335 |
| clinical trials | 0.629959 |
|
CLICK HERE |
| 1637 |
National Cancer Institute |
Html |
en |
Coenzyme Q10 (PDQ®)–Patient Version |
Coenzyme Q10 is naturally made by the body and can be taken as a pill or injection. Studies have shown it to help protect the heart from damaging side effects of doxorubicin and to stimulate the immune system in cancer patients. Read about the results of clinical trials in cancer patients using coenzyme Q10 in this expert-reviewed summary. |
| cancer treatment | 0.549646 |
| body | 0.488461 |
| PDQ cancer information | 0.604928 |
| Cancer Complementary | 0.504149 |
| clinical trials | 0.78289 |
| CoQ10 supplements | 0.61864 |
| health care providers | 0.511973 |
| mg CoQ10 | 0.629362 |
| cancer information summary | 0.559761 |
| alternative cancer therapies | 0.503732 |
| clinical trial | 0.520374 |
| CAM cancer research | 0.490752 |
| free radicals | 0.529211 |
| therapies | 0.527068 |
| conventional cancer therapies | 0.505246 |
| breast cancer patients | 0.577878 |
| patients | 0.653188 |
| cancer patients | 0.613167 |
| adjuvant therapy | 0.48477 |
| CoQ10 therapy | 0.668716 |
| NCI PDQ cancer | 0.520611 |
| cancer information database | 0.499763 |
| CoQ10 analogs | 0.637275 |
| Therapies Editorial Board | 0.506627 |
|
| cancer information | 0.615008 |
| treatment | 0.639358 |
| cancer prevention | 0.483763 |
| Complementary Therapies Editorial | 0.521183 |
| CoQ10 | 0.914047 |
| Drug Administration | 0.508672 |
| Cancer Information Specialist | 0.495609 |
| cancer cells | 0.510132 |
| Cancer Information Service | 0.558797 |
| treatment clinical trials | 0.486207 |
| National Cancer Institute | 0.655789 |
| studies | 0.570221 |
| alternative medicine | 0.536733 |
| health care | 0.547179 |
| scientific journals | 0.497807 |
| Federal Trade Commission | 0.485869 |
| new treatment | 0.531574 |
| Cancer Care page | 0.483491 |
| breast cancer | 0.62622 |
| animal studies | 0.506664 |
| cancer clinical trials | 0.505899 |
| alternative therapies | 0.521758 |
| cancer information summaries | 0.500194 |
| cancer | 0.924813 |
|
CLICK HERE |
| 1658 |
National Cancer Institute |
Html |
en |
Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of childhood medulloblastoma, nonmedulloblastoma embryonal tumors, and pineal tumors. |
| clinical trial | 0.453805 |
| treatment | 0.609377 |
| general information | 0.246182 |
| childhood cns | 0.275323 |
| nonmedulloblastoma embryonal tumors | 0.299989 |
| cancer cells | 0.278431 |
| embryonal tumors | 0.938688 |
| brain | 0.391786 |
| chemotherapy | 0.262908 |
| CNS embryonal tumors | 0.85028 |
| clinical trial search | 0.248648 |
|
| cancer clinical trials | 0.254529 |
| brain tumors | 0.23742 |
| stem cell rescue | 0.406691 |
| children | 0.244267 |
| radiation therapy | 0.844353 |
| clinical trials | 0.725208 |
| cancer | 0.65116 |
| standard treatment | 0.256014 |
| information | 0.249598 |
| spinal cord | 0.615415 |
| CNS embryonal tumor | 0.222757 |
|
CLICK HERE |
| 2027 |
National Cancer Institute |
Html |
es |
Prevención del cáncer colorrectal (PDQ®)–Versión para pacientes |
Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer colorrectal y sobre las investigaciones dirigidas a prevenir esta enfermedad. |
| Problemas renales | 0.523957 |
| siguientes factores | 0.953317 |
| voluntarios sanos | 0.523051 |
| Physician Data Query | 0.604817 |
| siguientes afecciones | 0.551171 |
| Estados Unidos | 0.609005 |
| posibles daños | 0.574254 |
| cuerpo).ampliar anatomÃa | 0.537676 |
| suficiente ejercicio | 0.534096 |
| prevención revisa | 0.526315 |
|
| menor riesgo | 0.62051 |
| PDQ Prevención | 0.545917 |
| Antecedentes familiares | 0.532247 |
| National Cancer Institute | 0.526671 |
| tumores benignos | 0.586261 |
| siguientes riesgos | 0.524072 |
| siguientes sumarios | 0.58101 |
| alto contenido | 0.561192 |
| Instituto Nacional | 0.54913 |
|
CLICK HERE |
| 3515 |
National Cancer Institute |
Html |
en |
Types of Clinical Trials |
Information about the several types of cancer clinical trials, including treatment trials, prevention trials, screening trials, supportive and palliative care trials. Each type of trial is designed to answer different research questions. |
| agent studies | 0.634708 |
| large number | 0.487416 |
| treatment studies | 0.534627 |
| unnecessary follow-up tests | 0.564207 |
| standard treatments | 0.500667 |
| palliative care trials | 0.620026 |
| nutrition problems | 0.486132 |
| approach prevent cancer | 0.592087 |
| specific changes | 0.499234 |
| researchers | 0.486118 |
| cancer patients | 0.507417 |
| treatment trials | 0.63562 |
| Cancer prevention trials | 0.614093 |
| healthy people | 0.501177 |
| cancer screening trials | 0.613302 |
| chemoprevention studies | 0.50869 |
| health problems | 0.485883 |
| high risk | 0.560244 |
| radiation therapy | 0.500589 |
| new ways | 0.649746 |
| safe dose | 0.499447 |
| life | 0.456389 |
| answers questions | 0.498733 |
| action studies | 0.564584 |
| dietary supplements | 0.491505 |
|
| studies | 0.663766 |
| newer treatment trials | 0.614927 |
| certain medicines | 0.490022 |
| different research questions | 0.599262 |
| new treatment | 0.895243 |
| sleep disorders | 0.486249 |
| disease | 0.456977 |
| effective screening test | 0.579302 |
| certain type | 0.487292 |
| support groups | 0.492526 |
| people | 0.64215 |
| better quality | 0.492262 |
| genetic changes | 0.499368 |
| new treatment help | 0.724782 |
| tumors | 0.439813 |
| cancer clinical trials | 0.74573 |
| new places | 0.514069 |
| trials | 0.781895 |
| treatment help people | 0.60481 |
| cancer risk | 0.517947 |
| cancer | 0.948957 |
| prevention trials | 0.744319 |
| new cancer | 0.533494 |
| test new treatments | 0.617153 |
|
CLICK HERE |
| 3650 |
National Cancer Institute |
Html |
en |
CRISPR: Genome Editing Comes of Age |
A research article about a technique for gene editing known as CRISPR-Cas9. The technique has made it much easier and faster for cancer researchers to study mutations and test new therapeutic targets. |
| next-generation DNA sequencing | 0.3795 |
| new targets | 0.314335 |
| activator-like effector nucleases | 0.397418 |
| potentially druggable genes | 0.453893 |
| future combination therapy | 0.360962 |
| cancer therapy | 0.352224 |
| unique gene | 0.31507 |
| cancer growth | 0.426678 |
| abnormal regulatory networks | 0.387625 |
| cancer cell line | 0.572636 |
| short palindromic repeats | 0.389333 |
| genome editing | 0.387426 |
| new therapeutic targets | 0.398394 |
| genes | 0.545435 |
| cell division | 0.314215 |
| Cancer phenotypes | 0.335586 |
| human cell | 0.318044 |
| target genes | 0.365123 |
| lymphoma cells | 0.394771 |
| cancer drug targets | 0.463263 |
| drug resistant tumors | 0.385077 |
| David Baltimore | 0.313639 |
| Ji Luo | 0.374003 |
| drug resistance | 0.449373 |
|
| DNA sequencing | 0.398873 |
| potential combination therapies | 0.357658 |
| possible therapeutic approaches | 0.357025 |
| gene targets | 0.319574 |
| gene expression—it | 0.322364 |
| drug resistance question | 0.384228 |
| CRISPR libraries | 0.319128 |
| cancer cells | 0.810099 |
| cancer cell lines | 0.446525 |
| Dr. Luo | 0.937997 |
| Dr. Staudt | 0.543567 |
| CRISPR method | 0.325677 |
| CRISPR technology | 0.334008 |
| Hannover Medical School | 0.387381 |
| Cancer Research | 0.352397 |
| normal cells | 0.431696 |
| cancer researchers | 0.367853 |
| CRISPR | 0.510355 |
| cell death | 0.314175 |
| transformative technology | 0.318261 |
| technology | 0.365907 |
| Cancer Genome Atlas | 0.450206 |
| gene editing | 0.330972 |
| genetic changes | 0.316809 |
|
CLICK HERE |
| 4288 |
National Cancer Institute |
Html |
en |
Delirium and Cancer Treatment |
Delirium is a confused mental state. Symptoms may include changes in thinking and sleeping. In cancer patients, it may be caused by medicine, dehydration, or happen at the end of life. Delirium may be mistaken for depression or dementia. |
| familiar possessions | 0.460098 |
| hyperactive delirium | 0.731474 |
| questions | 0.420272 |
| family member | 0.493907 |
| health care team | 0.510247 |
| brain tumors | 0.464705 |
| poor nutrition | 0.45797 |
| judgment | 0.429189 |
| awareness | 0.413241 |
| dehydration | 0.454891 |
| health care providers | 0.496178 |
| family members | 0.628462 |
| high doses | 0.463949 |
| risk factors | 0.511453 |
| Control surroundings | 0.456835 |
| patterns | 0.413223 |
| list | 0.42027 |
| bowels | 0.414692 |
| symptoms | 0.455716 |
| hypoactive delirium | 0.762002 |
| careful observation | 0.458029 |
| Early monitoring | 0.462105 |
| decision-making | 0.411721 |
| Mixed delirium | 0.689111 |
| older age | 0.46515 |
|
| dementia | 0.412808 |
| conditions | 0.42534 |
| mental state | 0.468032 |
| different treatments | 0.463034 |
| infection | 0.411593 |
| supportive care approaches | 0.497253 |
| sedation | 0.440043 |
| life | 0.425096 |
| causes | 0.425024 |
| certain medicines | 0.522455 |
| PDQ® summary | 0.45633 |
| end | 0.425106 |
| decisions | 0.423293 |
| behavior | 0.413211 |
| delirium | 0.955275 |
| short period | 0.469724 |
| main types | 0.467622 |
| advanced cancer | 0.462991 |
| patient changes | 0.458323 |
| withdrawal | 0.412724 |
| professional version | 0.456367 |
| doctor | 0.420247 |
| bladder | 0.411574 |
| time | 0.413034 |
|
CLICK HERE |
| 4383 |
National Cancer Institute |
Html |
en |
Anyone Can Get Skin Cancer |
No matter if your skin is light, dark, or somewhere in between, everyone is at risk for skin cancer. Learn what skin cancer looks like, how to find it early, and how to lower the chance of skin cancer. |
| skin cancer | 0.964567 |
| UV rays | 0.456636 |
| dark band | 0.53853 |
| new mole | 0.452556 |
| dark patch | 0.449539 |
| body | 0.421991 |
| waxy bump | 0.459872 |
| Wear sunglasses | 0.448376 |
| ) bump. | 0.459875 |
| talk | 0.420942 |
| common sign | 0.451092 |
| skin light | 0.47582 |
| different types | 0.451536 |
| jagged scar | 0.458002 |
| exposure | 0.417645 |
| medical conditions | 0.448166 |
| sore | 0.426359 |
| UVB rays | 0.455332 |
| broad spectrum | 0.449203 |
| women | 0.411421 |
| UVA | 0.425118 |
| sunscreen | 0.411184 |
| high level | 0.447722 |
| dark skin | 0.502452 |
| changes | 0.445228 |
|
| skin conditions | 0.464403 |
| cancer cells | 0.45646 |
| cell skin cancer | 0.522134 |
| firm red lump | 0.495754 |
| sun | 0.50802 |
| skin tone | 0.480812 |
| eyes | 0.41674 |
| old growth | 0.501248 |
| different color | 0.450303 |
| men | 0.411424 |
| certain medicines | 0.448412 |
| advanced skin cancers | 0.508812 |
| younger children | 0.460432 |
| change | 0.452939 |
| long sleeves | 0.44884 |
| No. | 0.411646 |
| skin ulcers | 0.466159 |
| people | 0.446457 |
| doctor | 0.48532 |
| sunlight | 0.422273 |
| cause damage | 0.452334 |
| new growth | 0.497988 |
| risk | 0.471314 |
| low level | 0.448421 |
|
CLICK HERE |